|
🐜
|
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
15 auth.
E. Brenner,
R. Ungaro,
R. Gearry,
G. Kaplan,
M. Kissous-Hunt,
J. Lewis,
S. Ng,
J. Rahier,
W. Reinisch,
F. Ruemmele,
...
F. Steinwurz,
F. Underwood,
Xian Zhang,
J. Colombel,
M. Kappelman
|
9 |
2020 |
9
🐜
|
|
🐜
|
Effect of IBD medications on COVID-19 outcomes: results from an international registry
14 auth.
R. Ungaro,
E. Brenner,
R. Gearry,
G. Kaplan,
M. Kissous-Hunt,
J. Lewis,
S. Ng,
J. Rahier,
W. Reinisch,
F. Steinwurz,
...
F. Underwood,
Xian Zhang,
J. Colombel,
M. Kappelman
|
7 |
2020 |
7
🐜
|
|
🐜
|
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
65 auth.
Z. Izadi,
E. Brenner,
S. Mahil,
N. Dand,
Zenas Z N Yiu,
M. Yates,
R. Ungaro,
Xian Zhang,
M. Agrawal,
J. Colombel,
M. Gianfrancesco,
K. Hyrich,
A. Strangfeld,
L. Carmona,
E. Mateus,
...
S. Lawson-Tovey,
E. Klingberg,
G. Cuomo,
M. Caprioli,
A. R. Cruz-Machado,
Ana Carolina Mazeda Pereira,
R. Hasseli,
A. Pfeil,
Hanns-Martin Lorenz,
B. Hoyer,
L. Trupin,
Stephanie Rush,
P. Katz,
G. Schmajuk,
L. Jacobsohn,
A. Seet,
Samar Al Emadi,
Leanna M. Wise,
Emily L Gilbert,
A. Duarte-García,
M. Valenzuela-Almada,
C. Isnardi,
R. Quintana,
E. Soriano,
T. Hsu,
K. D’Silva,
J. Sparks,
N. Patel,
R. Xavier,
C. Marques,
A. Kakehasi,
R. Flipo,
P. Claudepierre,
A. Cantagrel,
P. Goupille,
Z. Wallace,
S. Bhana,
W. Costello,
R. Grainger,
J. Hausmann,
J. Liew,
E. Sirotich,
P. Sufka,
P. Robinson,
P. Machado,
C. Griffiths,
J. Barker,
Catherine H. Smith,
J. Yazdany,
M. Kappelman
|
6 |
2021 |
6
🐜
|
|
🐜
|
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID
19 auth.
Kimberly N Weaver,
Xian Zhang,
Xiangfeng Dai,
R. Watkins,
J. Adler,
M. Dubinsky,
A. Kastl,
A. Bousvaros,
J. Strople,
R. Cross,
...
P. Higgins,
R. Ungaro,
M. Bewtra,
E. Bellaguarda,
F. Farraye,
M. Boccieri,
A. Firestine,
M. Kappelman,
M. Long
|
6 |
2021 |
6
🐜
|
|
🐜
|
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
22 auth.
M. Kappelman,
Kimberly N Weaver,
M. Boccieri,
A. Firestine,
Xian Zhang,
M. Long,
K. Chun,
M. Fernando,
M. Zikry,
X. Dai,
...
R. Watkins,
J. Adler,
M. Dubinsky,
A. Kastl,
A. Bousvaros,
J. Strople,
R. Cross,
P. Higgins,
R. Ungaro,
M. Bewtra,
E. Bellaguarda,
F. Farraye
|
6 |
2021 |
6
🐜
|
|
🐜
|
Incidence, Risk Factors, and Outcomes of Pouchitis and Pouch-related Complications in Patients with Ulcerative Colitis.
7 auth.
E. Barnes,
H. Herfarth,
M. Kappelman,
Xian Zhang,
A. Lightner,
M. Long,
...
R. Sandler
|
5 |
2020 |
5
🐜
|
|
🐜
|
Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
14 auth.
R. Ungaro,
E. Brenner,
M. Agrawal,
Xian Zhang,
M. Kappelman,
J. Colombel,
R. Gearry,
G. Kaplan,
M. Kissous-Hunt,
J. Lewis,
...
S. Ng,
J. Rahier,
W. Reinisch,
F. Steinwurz
|
5 |
2021 |
5
🐜
|
|
🐜
|
Multiple imaging techniques in the diagnosis of ampullary carcinoma.
7 auth.
Wei-xing Chen,
Q. Xie,
Weifang Zhang,
Xian Zhang,
Tian-Tian Hu,
Ping Xu,
...
Z. Gu
|
5 |
2008 |
5
🐜
|
|
🐜
|
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
8 auth.
M. Agrawal,
E. Brenner,
Xian Zhang,
Irene Modesto,
J. Woolcott,
R. Ungaro,
...
J. Colombel,
M. Kappelman
|
5 |
2020 |
5
🐜
|
|
🐜
|
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases
9 auth.
E. Brenner,
B. Pigneur,
G. Focht,
Xian Zhang,
R. Ungaro,
J. Colombel,
...
D. Turner,
M. Kappelman,
F. Ruemmele
|
5 |
2020 |
5
🐜
|
